Associated Papers
Structure, Function, Pathomechanisms and Targeting of TDP-43 in Neurodegeneration.
Zhang X et al.
Brain Research, 2026
Synaptopathy: presynaptic convergence in frontotemporal dementia and amyotrophic lateral sclerosis.
Clayton EL et al.
Brain : a Journal of Neurology, 2024
Astrocytes: Dissecting Their Diverse Roles in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
Valori CF et al.
Cells, 2023
The converging roles of sequestosome-1/p62 in the molecular pathways of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
Davidson JM et al.
Neurobiology of Disease, 2022
Modelling amyotrophic lateral sclerosis in rodents.
Todd TW et al.
Nature Reviews. Neuroscience, 2022
Synaptic dysfunction in ALS and FTD: anatomical and molecular changes provide insights into mechanisms of disease.
Gelon PA et al.
Frontiers in Molecular Neuroscience, 2022
Disrupted neuronal trafficking in amyotrophic lateral sclerosis.
Burk K et al.
Acta Neuropathologica, 2019
The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?
Hergesheimer RC et al.
Brain : a Journal of Neurology, 2019
From animal models to human disease: a genetic approach for personalized medicine in ALS.
Picher-Martel V et al.
Acta Neuropathologica Communications, 2016
Clinical and genetic basis of familial amyotrophic lateral sclerosis.
Souza PV et al.
Arquivos De Neuro-psiquiatria, 2015
Emerging mechanisms of molecular pathology in ALS.
Peters OM et al.
The Journal of Clinical Investigation, 2015
Progranulin and TDP-43: mechanistic links and future directions.
Kumar-Singh S
Journal of Molecular Neuroscience : Mn, 2011
FTD and ALS: a tale of two diseases.
Ferrari R et al.
Current Alzheimer Research, 2011
Pathogenic TARDBP mutations in amyotrophic lateral sclerosis and frontotemporal dementia: disease-associated pathways.
Barmada SJ et al.
Reviews in the Neurosciences, 2010
Select a paper to view details